-
1
-
-
78650774076
-
Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground
-
PID: 21199528
-
Chitturi S, Wong VW, Farrell G. Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol. 2011;26:163–172.
-
(2011)
J Gastroenterol Hepatol
, vol.26
, pp. 163-172
-
-
Chitturi, S.1
Wong, V.W.2
Farrell, G.3
-
2
-
-
65449156905
-
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study
-
PID: 19293782
-
Adams LA, Waters OR, Knuiman MW, et al. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol. 2009;104:861–867.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 861-867
-
-
Adams, L.A.1
Waters, O.R.2
Knuiman, M.W.3
-
3
-
-
84930788424
-
Nonalcoholic fatty liver disease: a systematic review
-
COI: 1:CAS:528:DC%2BC2MXhtFOkur7O, PID: 26057287
-
Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263–2273.
-
(2015)
JAMA
, vol.313
, pp. 2263-2273
-
-
Rinella, M.E.1
-
4
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
-
PID: 15565570
-
Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395.
-
(2004)
Hepatology
, vol.40
, pp. 1387-1395
-
-
Browning, J.D.1
Szczepaniak, L.S.2
Dobbins, R.3
-
5
-
-
84873909398
-
Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC38XhvVyisLjL, PID: 23236228
-
Li YY. Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol. 2012;18:6546–6551.
-
(2012)
World J Gastroenterol
, vol.18
, pp. 6546-6551
-
-
Li, Y.Y.1
-
6
-
-
84860246738
-
APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air
-
COI: 1:CAS:528:DC%2BC38XptVagtbk%3D, PID: 22369128
-
Duseja A, Aggarwal R. APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air. J Gastroenterol Hepatol. 2012;27:848–851.
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 848-851
-
-
Duseja, A.1
Aggarwal, R.2
-
7
-
-
84155174995
-
Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China
-
PID: 21898508
-
Li Y, Xing C, Cohen JC, et al. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China. Hepatology. 2012;55:327–328.
-
(2012)
Hepatology
, vol.55
, pp. 327-328
-
-
Li, Y.1
Xing, C.2
Cohen, J.C.3
-
8
-
-
84870622854
-
Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population
-
COI: 1:CAS:528:DC%2BC38XhvVKqtr%2FP, PID: 23226254
-
Peng XE, Wu YL, Lin SW, et al. Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population. PLoS One. 2012;7:e50256.
-
(2012)
PLoS One
, vol.7
, pp. 50256
-
-
Peng, X.E.1
Wu, Y.L.2
Lin, S.W.3
-
9
-
-
82455188122
-
I148 M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population
-
PID: 21793025
-
Li X, Zhao Q, Wu K, et al. I148 M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population. Hepatology. 2011;54:2275.
-
(2011)
Hepatology
, vol.54
, pp. 2275
-
-
Li, X.1
Zhao, Q.2
Wu, K.3
-
10
-
-
84937936637
-
Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B
-
COI: 1:CAS:528:DC%2BC2MXhslGrs7%2FM, PID: 26229402
-
Pan Q, Zhang RN, Wang YQ, et al. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B. World J Gastroenterol. 2015;21:8605–8614.
-
(2015)
World J Gastroenterol
, vol.21
, pp. 8605-8614
-
-
Pan, Q.1
Zhang, R.N.2
Wang, Y.Q.3
-
11
-
-
0008393474
-
Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes
-
COI: 1:CAS:528:DyaL2MXlvFSku7w%3D, PID: 3931073
-
Karathanasis SK. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci USA. 1985;82:6374–6378.
-
(1985)
Proc Natl Acad Sci USA
, vol.82
, pp. 6374-6378
-
-
Karathanasis, S.K.1
-
12
-
-
77950202777
-
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3cXjvFyjsLo%3D, PID: 20335584
-
Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med. 2010;362:1082–1089.
-
(2010)
N Engl J Med
, vol.362
, pp. 1082-1089
-
-
Petersen, K.F.1
Dufour, S.2
Hariri, A.3
-
13
-
-
9144226803
-
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
-
COI: 1:CAS:528:DC%2BD2cXmsVyltA%3D%3D, PID: 14563827
-
Olivieri O, Bassi A, Stranieri C, et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res. 2003;44:2374–2381.
-
(2003)
J Lipid Res
, vol.44
, pp. 2374-2381
-
-
Olivieri, O.1
Bassi, A.2
Stranieri, C.3
-
14
-
-
80052538156
-
Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons
-
COI: 1:CAS:528:DC%2BC3MXlslWgtLY%3D, PID: 21373834
-
van Hoek M, van Herpt TW, Dehghan A, et al. Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons. Diabetologia. 2011;54:1360–1367.
-
(2011)
Diabetologia
, vol.54
, pp. 1360-1367
-
-
van Hoek, M.1
van Herpt, T.W.2
Dehghan, A.3
-
15
-
-
52949105366
-
Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease
-
PID: 18801202
-
Shanker J, Perumal G, Rao VS, et al. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis. 2008;7:33.
-
(2008)
Lipids Health Dis
, vol.7
, pp. 33
-
-
Shanker, J.1
Perumal, G.2
Rao, V.S.3
-
16
-
-
34047135689
-
APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome
-
COI: 1:CAS:528:DC%2BD2sXjvFamsbs%3D, PID: 17416293
-
Miller M, Rhyne J, Chen H, et al. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome. Arch Med Res. 2007;38:444–451.
-
(2007)
Arch Med Res
, vol.38
, pp. 444-451
-
-
Miller, M.1
Rhyne, J.2
Chen, H.3
-
17
-
-
28344457689
-
Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake
-
COI: 1:CAS:528:DC%2BD2MXht1Olu73L, PID: 16326171
-
Herron KL, Lofgren IE, Adiconis X, et al. Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis. 2006;184:113–120.
-
(2006)
Atherosclerosis
, vol.184
, pp. 113-120
-
-
Herron, K.L.1
Lofgren, I.E.2
Adiconis, X.3
-
18
-
-
84910001923
-
Apolipoprotein C3 (−455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population
-
COI: 1:CAS:528:DC%2BC2cXhvFKrtL%2FJ, PID: 25320541
-
Li MR, Zhang SH, Chao K, et al. Apolipoprotein C3 (−455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population. World J Gastroenterol. 2014;20:14010–14017.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 14010-14017
-
-
Li, M.R.1
Zhang, S.H.2
Chao, K.3
-
19
-
-
84885381567
-
A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population
-
COI: 1:CAS:528:DC%2BC3sXhs1SmtLfI
-
Verrijken A, Beckers S, Francque S, et al. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Obesity (Silver Spring). 2013;21:2138–2145.
-
(2013)
Obesity (Silver Spring)
, vol.21
, pp. 2138-2145
-
-
Verrijken, A.1
Beckers, S.2
Francque, S.3
-
20
-
-
84860246794
-
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC38XptVagurY%3D, PID: 22141340
-
Hyysalo J, Stojkovic I, Kotronen A, et al. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2012;27:951–956.
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 951-956
-
-
Hyysalo, J.1
Stojkovic, I.2
Kotronen, A.3
-
21
-
-
81255198296
-
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver
-
COI: 1:CAS:528:DC%2BC3MXhsV2mt73N, PID: 21777557
-
Valenti L, Nobili V, Al-Serri A, et al. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J Hepatol. 2011;55:1409–1414.
-
(2011)
J Hepatol
, vol.55
, pp. 1409-1414
-
-
Valenti, L.1
Nobili, V.2
Al-Serri, A.3
-
22
-
-
84897490706
-
Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population
-
PID: 24707151
-
Niu TH, Jiang M, Xin YN, et al. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population. World J Gastroenterol. 2014;20:3655–3662.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 3655-3662
-
-
Niu, T.H.1
Jiang, M.2
Xin, Y.N.3
-
23
-
-
79251581867
-
Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010
-
PID: 21276207, (published in Chinese on Chinese Journal of Hepatology 2010; 18:163–166)
-
Fan JG, Jia JD, Li YM, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010. J Dig Dis. 2011;12:38–44. (published in Chinese on Chinese Journal of Hepatology 2010; 18:163–166).
-
(2011)
J Dig Dis
, vol.12
, pp. 38-44
-
-
Fan, J.G.1
Jia, J.D.2
Li, Y.M.3
-
24
-
-
75449091784
-
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3cXisVGgurk%3D, PID: 20101745
-
Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454–462.
-
(2010)
Hepatology
, vol.51
, pp. 454-462
-
-
Wong, V.W.1
Vergniol, J.2
Wong, G.L.3
-
25
-
-
78649630014
-
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis
-
PID: 20932598
-
Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54:64–71.
-
(2011)
J Hepatol
, vol.54
, pp. 64-71
-
-
Gaia, S.1
Carenzi, S.2
Barilli, A.L.3
-
26
-
-
84858276083
-
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C
-
COI: 1:STN:280:DC%2BC38rksVChtg%3D%3D, PID: 22404722
-
Sasso M, Tengher-Barna I, Ziol M, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C. J Viral Hepat. 2012;19:244–253.
-
(2012)
J Viral Hepat
, vol.19
, pp. 244-253
-
-
Sasso, M.1
Tengher-Barna, I.2
Ziol, M.3
-
27
-
-
84904747070
-
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC2cXht1WmsL7J, PID: 24753132
-
Bedossa P. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology. 2014;60:565–575.
-
(2014)
Hepatology
, vol.60
, pp. 565-575
-
-
Bedossa, P.1
-
28
-
-
33847022259
-
The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes
-
COI: 1:CAS:528:DC%2BD2sXitFyrtb8%3D, PID: 17197160
-
Dorfmeister B, Cooper JA, Stephens JW, et al. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes. Biochim Biophys Acta. 2007;1772:355–363.
-
(2007)
Biochim Biophys Acta
, vol.1772
, pp. 355-363
-
-
Dorfmeister, B.1
Cooper, J.A.2
Stephens, J.W.3
-
29
-
-
33947642520
-
Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes
-
COI: 1:CAS:528:DC%2BD2sXjslSlurw%3D, PID: 17367769
-
Fiegenbaum M, de Andrade FM, Hutz MH. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes. Clin Chim Acta. 2007;380:175–181.
-
(2007)
Clin Chim Acta
, vol.380
, pp. 175-181
-
-
Fiegenbaum, M.1
de Andrade, F.M.2
Hutz, M.H.3
-
30
-
-
18144416598
-
The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer’s disease in a Chinese population
-
COI: 1:CAS:528:DC%2BD2MXjvVOgtrc%3D, PID: 15862889
-
Sun Y, Shi J, Zhang S, et al. The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer’s disease in a Chinese population. Neurosci Lett. 2005;380:219–222.
-
(2005)
Neurosci Lett
, vol.380
, pp. 219-222
-
-
Sun, Y.1
Shi, J.2
Zhang, S.3
-
31
-
-
52949122489
-
Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD1cXhtFOmt77K, PID: 18789715
-
Sookoian S, Castano G, Gianotti TF, et al. Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease. Cytokine. 2008;44:201–206.
-
(2008)
Cytokine
, vol.44
, pp. 201-206
-
-
Sookoian, S.1
Castano, G.2
Gianotti, T.F.3
-
32
-
-
15744367999
-
Association study of calcitonin-receptor-like receptor gene in essential hypertension
-
COI: 1:CAS:528:DC%2BD2MXis1Khtrg%3D, PID: 15797661
-
Sano M, Kuroi N, Nakayama T, et al. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens. 2005;18:403–408.
-
(2005)
Am J Hypertens
, vol.18
, pp. 403-408
-
-
Sano, M.1
Kuroi, N.2
Nakayama, T.3
-
33
-
-
20144389168
-
A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-d glucosaminidase is associated with type 2 diabetes in Mexican Americans
-
COI: 1:CAS:528:DC%2BD2MXjtFWnuro%3D, PID: 15793264
-
Lehman DM, Fu DJ, Freeman AB, et al. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-d glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes. 2005;54:1214–1221.
-
(2005)
Diabetes
, vol.54
, pp. 1214-1221
-
-
Lehman, D.M.1
Fu, D.J.2
Freeman, A.B.3
-
34
-
-
11144357294
-
CREB binds to multiple loci on human chromosome 22
-
COI: 1:CAS:528:DC%2BD2cXjsVyrs7s%3D, PID: 15082775
-
Euskirchen G, Royce TE, Bertone P, et al. CREB binds to multiple loci on human chromosome 22. Mol Cell Biol. 2004;24:3804–3814.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 3804-3814
-
-
Euskirchen, G.1
Royce, T.E.2
Bertone, P.3
-
35
-
-
77957970113
-
A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents
-
COI: 1:CAS:528:DC%2BC3cXhtlejsrjO, PID: 20803499
-
Santoro N, Kursawe R, D’Adamo E, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology. 2010;52:1281–1290.
-
(2010)
Hepatology
, vol.52
, pp. 1281-1290
-
-
Santoro, N.1
Kursawe, R.2
D’Adamo, E.3
-
36
-
-
84857429794
-
Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms
-
PID: 22281838
-
Valenti L, Alisi A, Nobili V. Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms. Hepatology. 2012;55:661–663.
-
(2012)
Hepatology
, vol.55
, pp. 661-663
-
-
Valenti, L.1
Alisi, A.2
Nobili, V.3
-
37
-
-
84868235041
-
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
-
PID: 22707395
-
Bedossa P, Poitou C, Veyrie N, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56:1751–1759.
-
(2012)
Hepatology
, vol.56
, pp. 1751-1759
-
-
Bedossa, P.1
Poitou, C.2
Veyrie, N.3
-
38
-
-
84875577607
-
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives
-
PID: 23569334
-
Kim BK, Fung J, Yuen MF, et al. Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol. 2013;19:1890–1900.
-
(2013)
World J Gastroenterol
, vol.19
, pp. 1890-1900
-
-
Kim, B.K.1
Fung, J.2
Yuen, M.F.3
-
39
-
-
79958160803
-
Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans
-
COI: 1:CAS:528:DC%2BC3MXnslCns7s%3D, PID: 21663607
-
Sentinelli F, Romeo S, Maglio C, et al. Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. Lipids Health Dis. 2011;10:93.
-
(2011)
Lipids Health Dis
, vol.10
, pp. 93
-
-
Sentinelli, F.1
Romeo, S.2
Maglio, C.3
|